No Detail Found!

Novel extended-release carbamazepine oral suspension: Formulation, evaluation and drug-release kinetic study

Author(s)
Harith Jameel Mahdi Alsammarraie Department of Biotechnology, Faculty of Applied Sciences, University of Samarra,,Iraq
Menaa Abdulsalam Al-Abasi Department of Applied Chemistry, Faculty of Applied Sciences, University of Samarra,,Iraq
Adnan Majeed Mohammad Department of Applied Chemistry, Faculty of Applied Sciences, University of Samarra,,Iraq
Abstract
Common dosage forms have a number of drawbacks, including, but not exclusive, glitches in effectiveness, fluctuations in drug plasma concentration and poor patient's compliance. Such problems can be overcome by formulation of the drug as modified-release dosage forms. Usually, modified-release dosage forms are solid dosage form which are not proper for paediatrics and geriatrics. This research attempts to formulate and evaluate an extended-release carbamazepine oral suspension for paediatrics and geriatrics. Different ratios of Eudragit-L100 (Eud.) and PEG 4000 were used for encapsulation of carbamazepine powder. The selection of the best ratio was determined by dissolution test and FT-IR. The formulated ER suspensions were evaluated for organoleptic properties, pH, relative viscosity, density, sedimentation time, drug content and dissolution test. Additionally, drug release kinetics was studied to determine the possible mechanism of drug release. The best encapsulation ratio was (50:500:1000) PEG: Eud: Carbamazepine. Accordingly, formula 3 (F3) was selected. The evaluation tests showed an acceptable result. Mathematical analysis revealed that drug release kinetics following two kinetic models i.e. Hixson-Crowell and first-order model. The obtained results were encouraged to the possibility for manufacturing of first extended-release carbamazepine oral suspension. More in deep pre-clinical and clinical studies, in addition to production scale-up, are crucial.
Publication Details
Page(s) 1615-1624
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 37, Issue: 6, Year: 2024

Request the full text from PASTIC

Keywords
dissolution test, Encapsulation, Carbamazepine, Eudragit-L100, extended-release
References
Adepu S and Ramakrishna S .2021 .Controlled drug delivery systems: Current status and future directions. Molecules, 19 : 5905.
Alsammarraie HJM,Khan NAK,Mahmud R .2021 .Amphiphilic polymer for formulation of ethanol extract of Moringa oleifera leaves as solid dispersion: Formulation, evaluation and stability studies. Int. J. Drug Deliv, 11(3) : 926-936.
.2005 .ASEAN Guideline on stability study of drug product. Paper presented at the Proceedings of the 9th ACCSQ-PPWG Meeting, : 37.
Askarizadeh M,Esfandiari N,Honarvar B,Sajadian SA,Azdarpour A .2023 .Kinetic modeling to explain the release of medicine from drug delivery systems. Chem. Bio. Eng. Rev., 10(6) : 1006-1049.
Bolourchiana N,Mahboobiana MM,Dadashzadeh S MM .2013 .The effect of PEG molecular weights on dissolution behavior of simvastatin in solid dispersions. Iran J. Pharm. Res., 12 : 11-20.
Cetin M,Atila A,Kadioglu Y .2010 .Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium. AAPS Pharm Sci Tech., 11 : 3.
Dongyue Y,Jinghan L,Hanxun W,Hao P,Ting L,Tianshi B,Wei Z,Xiangrong Zhang Z .2022 .Role of polymers in the physical and chemical stability of amorphous solid dispersion: A case study of carbamazepine. Europ. J. Pharm. Sci., 169 : 106086.
Gouda R,Baishya H,Qing Z H .2017 .Application of mathematical models in drug release kinetics of Carbidopa and Levodopa ER tablets. J. Develop. Drugs, 6(171) : 2-11.
He M,Zhu L,Yang N,Li H,Yang Q .2021 .Recent advances of oral film as platform for drug delivery. Int. J. Pharm., 604 : 120759.
ICH-Q1A .2005 .Stability testing of new drug substances and products. , : .
Ke J,Chi M,Zhao J,Liu Y,Wang R,Fan K,Zhou Y,Xi Z,Kong X,Li H,Zeng J,Geng Z J .2023 .Dynamically reversible interconversion of molecular catalysts for efficient electro oxidation of propylene into propylene glycol. J. Am. Chem. Soc., 145(16) : 9104-9111.
Kestin J,Sokolov M,Wakeham WA M .1978 .Viscosity of liquid water in the range -8°C to 150°C. J. Phys. Chem. Ref. Data, 7(3) : 941-948.
Kim MH Kim DH,Nguyen DT,Lee HS,Kang NM,Baek MJ,An J,Yoo J,Yong-H W,Kim KT,Cho CW,Lee JY,Kim DD .2020 .Preparation and evaluation of Eudragit l100-peg proliponiosomes for enhanced oral delivery of celecoxib. , 12 : 718.
Maskova E,Naiserova M,Kubova K,Masek J,Pavlokova S,Urbanova M,Brus J,Vysloužil J,Vetchý D J .2019 .Highly soluble drugs directly granulated by water dispersions of insoluble Eudragit® polymers as a part of hypromellose k100m matrix systems. BioMed. Res. Int., : 2-13.
Clinic Mayo .2022 .. Carbamazepine (oral route), : .
Medina JR,Salazar DK,Hurtado MA,Cortes R,Dominguez-Ramirez AM .2014 .Comparative in vitro dissolution study of carbamazepine immediaterelease products using the USP paddles method and the flow-through cell system. Saudi Pharm. J., 22 : 141-147.
Nandy BC,Gupta A .2014 .A brief review on recent advances of extended release technology employed to design the oral dosage forms. Int. J. Med. Biomed. Studies, 1(6) : 12-24.
Paarakh MP,Jose PA,Setty CM,Peter GV CM .2018 .Release kinetics- concepts and applications. Int. J. Pharm. Res. Tech., 10 : .
Patra RK,Acharya AK,Mahapatra AK,Mallick S AK,Int AK,App AK .2023 .Solubility enhancement of rivaroxaban by solid dispersion with polyethylene glycol 4000. , 15(2) : 78-85.
Shamma RN,Aburahma MH,Mahmoud AA .2016 .Enhancement of carbamazepine dissolution by solid dispersion in peg 4000: Study of the mechanisms of drug-polymer interactions. AAPS Pharm Sci Tech., 17 : 187-198.
Tokunaga S,Ono K,Ito S,Sharmin T,Kato T,Irie K,Mishima K,Satho T,Harada T,Aida TM,Mishima K .2021 .Microencapsulation of drug with enteric polymer Eudragit L100 for controlled release using the particles from gas saturated solutions (PGSS) process. J. Supercrit. Fluids, 167 : 105044.
Tolou-Ghamari Z,Zare M,Habibabadi JM,Najaf MR .2013 .A quick review of carbamazepine pharmacokinetics in epilepsy from 1953 to 2012. J. Res. Med. Sci., Supplement, 1 : S81-S85.
State United .2020 .Pharmaceutical stability. United States Pharmacopeial Convention, : .
0

Citations

1

Downloads

66

Views